Pancreatic Cancer Research

ResearcherMemorial Sloan Kettering Cancer CenterActive in the last 2 years

Alvin P. Makohon-Moore

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-4781-3565; OpenAlex author ID A5036118290; NIH RePORTER profile ID 10610378. Sources: OpenAlex.

Their work

Papers
20
Trials
0
Grants
3
Labs led
1
Collaborators
77
Papers, trials and grants by year

2013: 2 papers · 2014: 1 grant · 2015: 2 papers · 2016: 2 papers · 2017: 4 papers · 2018: none · 2019: 2 papers · 2020: 3 papers, 1 grant · 2021: 1 paper · 2022: 1 paper · 2023: 1 paper · 2024: 1 grant · 2025: 2 papers

Papers 20

  1. The Evolutionary Forest of Pancreatic Cancer. Co-author DOI 10.1158/2159-8290.cd-23-1541↗
  2. The Noncoding Mutational Landscape of Pancreatic Cancer Reveals Recurrent Somatic Mutations in Enhancer Regions. Co-author DOI 10.1158/2767-9764.crc-24-0167↗
  3. Application of high-throughput single-nucleus DNA sequencing in pancreatic cancer. Co-author DOI 10.1038/s41467-023-36344-z↗
  4. Neoantigen quality predicts immunoediting in survivors of pancreatic cancer. Co-author DOI 10.1038/s41586-022-04735-9↗
  5. Pancreatic cancer prognosis is predicted by an ATAC-array technology for assessing chromatin accessibility. Co-author DOI 10.1038/s41467-021-23237-2↗
  6. A unifying paradigm for transcriptional heterogeneity and squamous features in pancreatic ductal adenocarcinoma. Co-author DOI 10.1038/s43018-019-0010-1↗
  7. Evolutionary Dynamics of Non-Coding Regions in Pancreatic Ductal Adenocarcinoma Co-author DOI 10.1101/2020.09.11.294389↗
  8. The Evolutionary Origins of Recurrent Pancreatic Cancer. Co-author DOI 10.1158/2159-8290.cd-19-1508↗
  9. Characterization of genetic subclonal evolution in pancreatic cancer mouse models. Co-author DOI 10.1038/s41467-019-13100-w↗
  10. The Genetic Basis of Transcriptional and Spatial Heterogeneity of Squamous Features in Pancreatic Ductal Adenocarcinoma Co-author DOI 10.1101/548354↗
  11. Epigenomic reprogramming during pancreatic cancer progression links anabolic glucose metabolism to distant metastasis. Co-author DOI 10.1038/ng.3753↗
  12. Limited heterogeneity of known driver gene mutations among the metastases of individual patients with pancreatic cancer. Co-author DOI 10.1038/ng.3764↗
  13. An unusual genomic variant of pancreatic ductal adenocarcinoma with an indolent clinical course. Co-author DOI 10.1101/mcs.a001701↗
  14. Mutant p53 Together with TGFβ Signaling Influence Organ-Specific Hematogenous Colonization Patterns of Pancreatic Cancer. Co-author DOI 10.1158/1078-0432.ccr-15-1615↗
  15. Pancreatic cancer biology and genetics from an evolutionary perspective. Co-author DOI 10.1038/nrc.2016.66↗
  16. Whole Genome Sequencing Defines the Genetic Heterogeneity of Familial Pancreatic Cancer. Co-author DOI 10.1158/2159-8290.cd-15-0402↗
  17. Transflip mutations produce deletions in pancreatic cancer. Co-author DOI 10.1002/gcc.22258↗
  18. Retrotransposon insertions in the clonal evolution of pancreatic ductal adenocarcinoma. Co-author DOI 10.1038/nm.3919↗
  19. Considerations for sequencing analyses of pancreatic cancer progression and metastasis. Co-author DOI 10.1007/978-1-62703-287-2_6↗
  20. Pancreatic cancer genomics: insights and opportunities for clinical translation. Co-author DOI 10.1186/gm430↗

Grants 3

  1. Experimental evolution of pancreatic cancer R00CA229979↗
  2. Experimental evolution of pancreatic cancer K99CA229979↗
  3. Subclonal Evolution in Metastatic Pancreatic Cancer F31CA180682↗

Closest collaborators

The 25 strongest of 77 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Christine A. Iacobuzio–Donahue · 20 shared papers, 2013–2025 · strength 1.80
  2. Jungeui Hong · 8 shared papers, 2017–2025 · strength 0.94
  3. Akimasa Hayashi · 7 shared papers, 2019–2025 · strength 0.89
  4. Marc A. Attiyeh · 7 shared papers, 2017–2025 · strength 0.64
  5. Zachary A. Kohutek · 7 shared papers, 2015–2025 · strength 0.57
  6. Laura DeLong Wood · 6 shared papers, 2016–2025 · strength 0.51
  7. Eileen Mary O'Reilly · 4 shared papers, 2020–2025 · strength 0.46
  8. Hitomi Sakamoto · 4 shared papers, 2019–2025 · strength 0.43
  9. Ralph H. Hruban MD · 7 shared papers, 2015–2020 · strength 0.40
  10. Katelyn Mullen · 2 shared papers, 2023–2025 · strength 0.36
  11. Caitlin A. McIntyre · 2 shared papers, 2023–2025 · strength 0.36
  12. Haochen Zhang · 2 shared papers, 2023–2025 · strength 0.36
  13. Yi Zhong · 5 shared papers, 2017–2020 · strength 0.36
  14. Johannes G. Reiter · 3 shared papers, 2017–2020 · strength 0.23
  15. Wungki Park · 1 shared paper, 2025 · strength 0.21
  16. Marinela Capanu · 1 shared paper, 2025 · strength 0.20
  17. Benjamin J. Raphael · 1 shared paper, 2025 · strength 0.20
  18. Vinod P. Balachandran · 2 shared papers, 2021–2022 · strength 0.19
  19. Steven D Leach · 2 shared papers, 2017–2021 · strength 0.15
  20. Olca Baştürk · 2 shared papers, 2019–2020 · strength 0.15
  21. Noushin Niknafs · 2 shared papers, 2016–2019 · strength 0.13
  22. Rachel Karchin · 2 shared papers, 2016–2019 · strength 0.13
  23. Joseph M. Herman · 2 shared papers, 2016–2017 · strength 0.11
  24. Benjamin D. Greenbaum · 1 shared paper, 2022 · strength 0.10
  25. Taha Merghoub Merghoub · 1 shared paper, 2022 · strength 0.10

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.